| Literature DB >> 30921429 |
Khoa Manh Dinh1, Kathrine Agergård Kaspersen1, Susan Mikkelsen1, Ole Birger Pedersen2, Mikkel Steen Petersen1, Lise Wegner Thørner3, Henrik Hjalgrim4,5, Klaus Rostgaard4, Henrik Ullum3, Christian Erikstrup1.
Abstract
BACKGROUND: Health-Related Quality of Life (HRQL) represent individuals' subjective assessment of their mental and physical well-being, and is highly predictive of future health. C-reactive protein (CRP) is a well-established marker of inflammation. Low-grade inflammation (LGI), defined as slightly increased CRP levels, is associated with increased risk of several diseases. LGI may reflect subclinical pathology, which could affect individual's subjective health assessment. This study aimed to examine whether LGI has an independent impact on self-reported health or rather is a mediator of a confounder in a large population of healthy individuals.Entities:
Mesh:
Substances:
Year: 2019 PMID: 30921429 PMCID: PMC6438577 DOI: 10.1371/journal.pone.0214468
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Characteristics of case-complete participants stratified by sex (n = 15,380).
| Women | Men | |
|---|---|---|
| 7,249 (47.3) | 8,131 (52.7) | |
| 37.8 (27.3; 47.8) | 40.1 (30.3; 49.7) | |
| 23.5 (21.5; 26.1) | 25.1 (23.3; 27.4) | |
| 673 (9.3) | 806 (9.9) | |
| 1,228 (17.1) | 1,292 (15.8) | |
| 82.0 (76.0; 90.0) | 92.0 (86.0; 99.0) | |
| 55.9 (53.9; 57.3) | 56.0 (53.9; 57.2) | |
| 53.5 (50.1; 56.7) | 54.8 (51.6; 56.8) | |
| 0.67 (0.19; 1.90) | 0.42 (0.11; 1.09) | |
| 1,056 (14.6) | 486 (6.0) | |
| 440 (6.1) | 177 (2.2) | |
| 2,143 (29.6) | - |
Numbers (%) or medians (interquartile ranges).
PCS: physical component score. MCS: mental component score.
* LGI defined as 3 mg/L
Mediation analysis of predictors for physical component score with LGI as mediator on case-complete participants with adjustments (n = 14,371).
| Women using OC (n = 1,984) | Women not using OC (n = 4,770) | Men (n = 7,617) | ||||
|---|---|---|---|---|---|---|
| Outcome PCS / Mediator LGI | RC | 95% CI | RC | 95% CI | RC | 95% CI |
| ACME | -0.002 | -0.006; -0.0002 | -0.0005 | -0.001; 0.0001 | -0.0003 | -0.0006; 0.0001 |
| Direct effect | -0.057 | -0.12; -0.01 | -0.086 | -0.13; -0.04 | -0.11 | -0.15; -0.06 |
| Total effect | -0.059 | -0.12; -0.01 | -0.086 | -0.13; -0.04 | -0.11 | -0.15; -0.06 |
| Proportion of total effect (%) | 3.3 | -2.3; 18.6 | 0.5 | 0.4; 1.1 | 0.2 | 0.1; 0.4 |
| ACME | 0.006 | -0.02; 0.03 | -0.02 | -0.05; -0.003 | -0.03 | -0.05; -0.01 |
| Direct effect | -0.65 | -1.10; -0.18 | -0.64 | -0.92; -0.36 | -0.56 | -0.77; -0.35 |
| Total effect | -0.64 | -1.09; -0.17 | -0.66 | -0.94; -0.37 | -0.59 | -0.80; -0.37 |
| Proportion of total effect (%) | -1.0 | -3.4; -0.6 | 3.0 | 2.1; 5.3 | 4.8 | 3.5; 7.6 |
| ACME | -0.01 | -0.03; -0.002 | 0.001 | -0.001; 0.006 | -0.004 | -0.006; -0.001 |
| Direct effect | 0.14 | -0.08; 0.36 | -0.27 | -0.33; -0.20 | -0.18 | -0.26; -0.10 |
| Total effect | 0.13 | -0.09; 0.36 | -0.26 | -0.34; -0.19 | -0.18 | -0.26; -0.10 |
| Proportion of total effect (%) | -6.3 | -98.3; 80.7 | -0.5 | -0.7; -0.4 | 2.0 | 1.4; 3.6 |
| ACME | -0.01 | -0.03; 0.002 | -0.004 | -0.01; 0.0001 | 0.005 | -5.57·10^-18; 0.001 |
| Direct effect | -0.46 | -0.61; -0.30 | -0.38 | -0.48; -0.28 | -0.42 | -0.52; -0.32 |
| Total effect | -0.47 | -0.62; -0.31 | -0.39 | -0.48; -0.28 | -0.42 | -0.52; -0.31 |
| Proportion of total effect (%) | 2.2 | 1.7; 3.3 | 1.0 | 0.8; 1.4 | -1.2 | -1.7; -1.0 |
| ACME | -0.01 | -0.03; -0.06 | -0.01 | -0.03; 0.002 | -0.01 | -0.02; 0.005 |
| Direct effect | -0.11 | -0.50; 0.30 | -0.42 | -0.67; -0.16 | -0.53 | -0.72; -0.33 |
| Total effect | -0.12 | -0.50; 0.30 | -0.43 | -0.68; -0.17 | -0.54 | -0.72; -0.33 |
| Proportion of total effect (%) | 2.1 | -48.8; 60.0 | 2.1 | 1.3; 5.2 | 1.1 | 0.8; 1.7 |
| ACME | 0.01 | -0.0002; 0.04 | 0.01 | 0.02; 0.03 | 0.01 | -0.02; 0.02 |
| Direct effect | 0.48 | 0.16; 0.82 | 0.74 | 0.52; 0.97 | 0.70 | 0.57; 0.84 |
| Total effect | 0.49 | 0.18; 0.84 | 0.75 | 0.54; 0.99 | 0.71 | 0.58; 0.85 |
| Proportion of total effect (%) | 2.8 | 1.7; 7.9 | 1.7 | 1.3; 2.4 | 0.9 | 0.8; 1.1 |
RC: regression coefficient, OC: combined oral contraception, PCS: physical component score, MCS: mental component score, CRP: C-reactive protein, BMI: body mass index, LGI: low-grade inflammation (defined as 3 mg/L < CRP ≤ 10 mg/L), CI: confidence interval
Note: Analysis performed without missing responses in waist circumference variable
Predictors of PCS and MCS estimated by multiple imputation of multivariable linear regression analysis (n = 17,024).
| Women using OC (n = 2,249) | Women not using OC (n = 5,984) | Men (n = 8,791) | Men and women not using OC (n = 14,775) | |||||
|---|---|---|---|---|---|---|---|---|
| Low-grade inflammation (LGI) | -0.37 | (-0.72; -0.03) | -0.81 | (-1.22;-0.39) | -0.80 | (-1.14;-0.47) | -0.74 | (-1.12;-0.35) |
| BMI (kg/m2) | -0.06 | (-0.13; -0.01) | -0.08 | (-0.12;-0.003) | -0.11 | (-0.14;-0.07) | -0.09 | (-0.12;-0.06) |
| Current smoker (yes/no) | -0.71 | (-1.13; -0.29) | -0.66 | (-0.95;-0.37) | -0.60 | (-0.82;-0.38) | -0.62 | (-0.80;-0.45) |
| Age (10 year increment) | 0.12 | (-0.10; 0.35) | -0.29 | (-0.38;-0.20) | -0.16 | (-0.23;-0.10) | -0.21 | (-0.27;-0.16) |
| Waist (10 cm increment) | -0.39 | (-0.61; -0.17) | -0.27 | (-0.42;-0.11) | -0.29 | (-0.40;-0.18) | -0.29 | (-0.37;-0.20) |
| Physical activity, work (low/high) | -0.18 | (-0.61; 0.18) | -0.41 | (-0.67;-0.15) | -0.53 | (-0.72;-0.35) | -0.49 | (-0.64;-0.34) |
| Physical activity, leisure (low/high) | 0.49 | (0.16; 0.83) | 0.77 | (0.53;1.00) | 0.70 | (0.53;0.88) | 0.73 | (0.59;0.87) |
| Female | -0.26 | (-0.39;-0.13) | ||||||
| Female x LGI | -0.19 | (-0.71; 0.25) | ||||||
| Low-grade inflammation (LGI) | 0.25 | (-0.40;0.89) | -0.15 | (-0.81;0.51) | 0.001 | (-0.52;0.53) | 0.04 | (-0.57;0.65) |
| BMI (kg/m2) | -0.004 | (-0.13;0.12) | 0.06 | (-0.01;0.12) | -0.03 | (-0.08;0.03) | 0.01 | (-0.03;0.05) |
| Current smoker (yes/no) | -1.12 | (-1.90;-0.34) | -0.89 | (-1.34;-0.44) | -0.84 | (-1.18;-0.50) | -0.86 | (-1.13;-0.59) |
| Age (10 year increment) | 1.10 | (0.68;1.52) | 1.20 | (1.05;1.34) | 0.97 | (0.87;1.08) | 1.05 | (0.97;1.14) |
| Waist (10 cm increment) | -0.36 | (-0.77;0.006) | -0.09 | (-0.34;0.16) | -0.09 | (-0.18;0.17) | -0.04 | (-0.18;0.10) |
| Physical activity, work (low/high) | -0.13 | (-0.83;0.57) | 0.47 | (0.06;0.88) | 0.61 | (0.32;0.90) | 0.54 | (0.30;0.77) |
| Physical activity, leisure (low/high) | 1.05 | (0.43;1.67) | 1.04 | (0.68;1.41) | 1.15 | (0.88;1.43) | 1.08 | (0.85;1.31) |
| Female | 1.05 | (0.84;1.27) | ||||||
| Female x LGI | -0.12 | (-0.91;0.53) | ||||||
RC: regression coefficient, OC: combined oral contraception, PCS: physical component score, MCS: mental component score, CRP: C-reactive protein, BMI: body mass index, LGI defined as 3 mg/L < CRP ≤ 10 mg/L, CI: confidence interval.
* Note: Analysis performed without missing responses in abdominal obesity variable.
Predictors of PCS and MCS estimated by linear regression analysis adjusted for age of case-complete participants (n = 15,380).
| Women using OC (n = 2,143) | Women not using OC (n = 5,106) | Men (n = 8,131) | Men and women not using OC (n = 13,237) | |||||
|---|---|---|---|---|---|---|---|---|
| Low-grade inflammation (LGI) | -0.77 | (-1.10; -0.44) | -1.54 | (-1.95; -1.14) | -1.32 | (-1.67; -0.98) | -1.53 | (-1.94; -1.16) |
| Age (10 year increment) | -0.04 | (-0.25; 0.18) | -0.35 | (-0.44; -0.26) | -0.29 | (-0.36; -0.23) | -0.32 | (-0.37; -0.26) |
| Female | 0.04 | (-0.18; 0.10) | ||||||
| Female x LGI | 0.23 | (-0.30; 0.76) | ||||||
| Low-grade inflammation (LGI) | -0.04 | (-0.66; 0.57) | -0.16 | (-0.80; 0.48) | 0.17 | (-0.70; 0.6) | -0.13 | (-0.74; 0.47) |
| Age (10 year increment) | 0.99 | (0.59; 1.39) | 1.23 | (1.08; 1.37) | 0.99 | (0.88; 1.09) | 1.07 | (0.99; 1.16) |
| Female | 1.14 | (0.92; 1.36) | ||||||
| Female x LGI | -0.07 | (-0.88; 0.75) | ||||||
RC: regression coefficient, OC: combined oral contraception, PCS: physical component score, MCS: mental component score, CRP: C-reactive protein, LGI defined as 3 mg/L < CRP ≤ 10 mg/L, CI: confidence interval.
Predictors of PCS and MCS estimated by multivariable linear regression analysis of case-complete participants (n = 14,371).
| Women using OC (n = 1,984) | Women not using OC (n = 4,770) | Men (n = 7,617) | Men and women not using OC (n = 12,387) | |||||
|---|---|---|---|---|---|---|---|---|
| Low-grade inflammation (LGI) | -0.36 | (-0.94; -0.19) | -0.63 | (-1.05; -0.21) | -0.76 | (-1.10; -0.42) | -0.78 | (-1.13; -0.44) |
| BMI (kg/m2) | -0.06 | (-0.13; -0.01) | -0.09 | (-0.13; -0.04) | -0.11 | (-0.14; -0.07) | -0.10 | (-0.12; -0.07) |
| Current smoker (yes/no) | -0.67 | (-1.09; -0.25) | -0.67 | (-0.95; -0.38) | -0.57 | (-0.80; -0.36) | -0.62 | (-0.79; -0.44) |
| Age (10 year increment) | 0.14 | (-0.07; 0.36) | -0.26 | (-0.36; -0.17) | -0.16 | (-0.23; -0.09) | -0.20 | (-0.26; -0.15) |
| Waist (10 cm increment) | -0.39 | (-0.62; -0.17) | -0.25 | (-0.41; -0.09) | -0.30 | (-0.41; -0.19) | -0.29 | (-0.38; -0.19) |
| Physical activity, work (low/high) | -0.11 | (-0.49; 0.27) | -0.43 | (-0.69; -0.17) | -0.51 | (-0.70; -0.33) | -0.48 | (-0.64; -0.33) |
| Physical activity, leisure (low/high) | 0.48 | (0.14; 0.81) | 0.73 | (0.50; 0.96) | 0.70 | (0.52; 0.87) | 0.71 | (0.57; 0.85) |
| Female | -0.18 | (-0.48; 0.12) | ||||||
| Female x LGI | -0.02 | (-0.54; 0.49) | ||||||
| Low-grade inflammation (LGI) | 0.27 | (-0.37; 0.92) | -0.05 | (-0.73; 0.62) | 0.04 | (-0.49; 0.57) | 0.12 | (-0.50; 0.74) |
| BMI (kg/m2) | -0.005 | (-0.13; 0.12) | 0.05 | (-0.02; 0.12) | -0.03 | (-0.08; 0.03) | 0.01 | (-0.04; 0.05) |
| Current smoker (yes/no) | -1.05 | (-1.83; -0.26) | -0.89 | (-1.35; -0.43) | -0.82 | (-1.16; -0.47) | -0.84 | (-1.12; -0.57) |
| Age (10 year increment) | 1.17 | (0.76; 1.58) | 1.24 | (1.09; 1.39) | 1.00 | (0.90; 1.11) | 1.08 | (1.01; 1.17) |
| Waist (10 cm increment) | -0.40 | (-0.82; 0.019) | -0.12 | (-0.37; 0.13) | -0.03 | (-0.21; 0.15) | -0.06 | (-0.21; -0.08) |
| Physical activity, work (low/high) | -0.08 | (-0.79; 0.62) | 0.47 | (-0.05; 0.90) | 0.64 | (0.35; 0.93) | 0.56 | (0.32; 0.80) |
| Physical activity, leisure (low/high) | 0.99 | (0.36; 1.61) | 1.04 | (0.68; 1.42) | 1.16 | (0.88; 1.44) | 1.11 | (0.89; 1.34) |
| Female | 1.01 | (0.79; 1.24) | ||||||
| Female x LGI | -0.12 | (-0.94; 0.69) | ||||||
RC: regression coefficient, OC: combined oral contraception, PCS: physical component score, MCS: mental component score, CRP: C-reactive protein, BMI: body mass index, LGI defined as 3 mg/L < CRP ≤ 10 mg/L, CI: confidence interval.
Note: Analysis performed without missing responses in abdominal obesity variable
Mediation analysis of predictors for mental component score with LGI as mediator on case-complete participants with adjustments (n = 14,371).
| Women using OC (n = 1,984) | Women not using OC (n = 4,770) | Men (n = 7,617) | ||||
|---|---|---|---|---|---|---|
| Outcome MCS / Mediator LGI | RC | 95% CI | RC | 95% CI | RC | 95% CI |
| ACME | 0.001 | -0.001; 0.006 | -0.00003 | -0.0006; 0.0007 | 0.00001 | -0.0002; 0.0002 |
| Direct effect | 0.001 | -0.14; 0.15 | 0.05 | -0.001; 0.10 | -0.03 | -0.07; 0.02 |
| Total effect | 0.003 | -0.14; 0.15 | 0.05 | -0.002; 0.10 | -0.03 | -0.07; 0.02 |
| Proportion of total effect (%) | 0.9 | -24.4; 37.9 | -0.006 | -0.4; 0.2 | -0.04 | -0.6; 0.4 |
| ACME | -0.05 | -0.03; 0.01 | -0.003 | -0.03; 0.02 | 0.001 | -0.02; 0.02 |
| Direct effect | -1.01 | -1.72; -0.28 | -0.87 | -1.34; -0.39 | -0.80 | -1.16; -0.43 |
| Total effect | -1.02 | -1.72; -0.29 | -0.88 | -1.34; -0.40 | -0.80 | -1.16; -0.43 |
| Proportion of total effect (%) | 0.5 | 0.3; 1.6 | 0.3 | 0.2; 0.8 | -0.001 | -0.1; -0.05 |
| ACME | 0.01 | -0.01; 0.03 | 0.0001 | -0.002; 0.03 | 0.0001 | -0.003; 0.03 |
| Direct effect | 1.18 | 0.81; 1.56 | 1.25 | 1.12; 1.39 | 1.00 | 0.91; 1.10 |
| Total effect | 1.19 | 0.82; 1.57 | 1.25 | 1.12; 1.39 | 1.00 | 0.91; 1.10 |
| Proportion of total effect (%) | 0.6 | 0.5; 0.9 | 0.01 | 0.013; 0.02 | 0.01 | 0.013; 0.02 |
| ACME | 0.0007 | -0.0007; 0.002 | -0.0005 | -0.006; 0.004 | -0.000009 | -0.005; 0.005 |
| Direct effect | -0.35 | -0.67; -0.02 | -0.08 | -0.28; 0.13 | -0.08 | -0.23; 0.08 |
| Total effect | -0.34 | -0.66; -0.01 | -0.08 | -0.28; 0.13 | -0.08 | -0.23; 0.08 |
| Proportion of total effect (%) | -2.0 | -10.2; 0.9 | 0.4 | -7.5; 8.2 | 0.1 | -1.0; 1.0 |
| ACME | 0.004 | -0.01; 0.03 | -0.001 | -0.01; 0.01 | 0.0001 | -0.01; 0.01 |
| Direct effect | -0.06 | -0.63; 0.54 | 0.49 | 0.10; 0.90 | 0.64 | 0.35; 0.94 |
| Total effect | -0.06 | -0.63; 0.54 | 0.49 | 0.10; 0.90 | 0.64 | 0.35; 0.94 |
| Proportion of total effect (%) | -0.9 | -20.6; 18.3 | -0.2 | -1.1; -0.1 | 0.02 | 0.01; 0.03 |
| ACME | -0.01 | -0.04; 0.01 | 0.002 | -0.01; 0.02 | -0.0001 | -0.01; 0.01 |
| Direct effect | 1.00 | 0.42; 1.61 | 1.06 | 0.67; 1.47 | 1.17 | 0.91; 1.45 |
| Total effect | 0.99 | 0.42; 1.59 | 1.06 | 0.68; 1.47 | 1.17 | 0.91; 1.45 |
| Proportion of total effect (%) | -1.0 | -2.4; -0.6 | 0.2 | 0.1; 0.3 | -0.01 | -0.01; -0.008 |
RC: regression coefficient, OC: combined oral contraception, PCS: physical component score, MCS: mental component score, CRP: C-reactive protein, BMI: body mass index, LGI: low-grade inflammation (defined as 3 mg/L < CRP ≤ 10 mg/L), CI: confidence interval
Note: Analysis performed without missing responses in waist circumference variable